Regulation of p53 activity through lysine methylation

Nature

Volumn 432, Issue 7015, 2004, Pages 353-360

  Chuikov, Sergei ^a   Kurash, Julia K ^b   Wilson, Jonathan R ^c   Xiao, Bing ^c   Justin, Neil ^c   Ivanov, Gleb S ^b   McKinney, Kristine ^d   Tempst, Paul ^e   Prives, Carol ^d   Gamblin, Steven J ^c   Barlev, Nickolai A ^b   Reinberg, Danny ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL STRUCTURE; PROTEINS;

CELLULAR RESPONSE; LYSINE; TUMOUR SUPPRESSORS;

TUMORS;

LYSINE; METHYLTRANSFERASE; PROTEIN P53; S ADENOSYLHOMOCYSTEINE;

CANCER;

ACETYLATION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DERIVATIZATION; GENE EXPRESSION REGULATION; GENE TARGETING; GENOTOXICITY; METHYLATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; PROTEIN TERTIARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; APOPTOSIS; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENES, P53; GENES, RAS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LYSINE; METHYLATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN CONFORMATION; RNA, MESSENGER; S-ADENOSYLHOMOCYSTEINE; SUBSTRATE SPECIFICITY; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 9244247669     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03117     Document Type: Article

References (22)

1. Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
2. Wang, H. et al. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8, 1207-1217 (2001).
3. Nishioka, K. et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 16, 479-489 (2002).
4. Appella, E. & Anderson, C. W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268, 2764-2772 (2001).
5. Shieh, S. Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334 (1997).
6. Momand, J., Wu, H. H. & Dasgupta, G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242, 15-29 (2000).
7. Brooks, C. L. & Gu, W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. 15, 164-171 (2003).
8. Li, M., Luo, J., Brooks, C. L. & Gu, W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 277, 50607-50611 (2002).
9. Luo, J. et al. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl Acad. Sci. USA 101, 2259-2264 (2004).
10. Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (1997).
11. Barlev, N. A. et al. Acetylation of p53 activates transcription through recruitment of coactivators/ histone acetyltransferases. Mol. Cell 8, 1243-1254 (2001).
12. Gu, W., Luo, J., Brooks, C. L., Nikolaev, A. Y. & Li, M. Dynamics of the p53 acetylation pathway. Nov. Found. Symp. 259, 197-205 (2004).
13. Gostissa, M. et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. Embo J. 18, 6462-6471 (1999).
14. Kwek, S. S., Derry, J., Tyner, A. L., Shen, Z. & Gudkov, A. V. Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 20, 2587-2599 (2001).
15. Rodriguez, M. S. et al. SUMO-1 modification activates the transcriptional response of p53. Embo J. 18, 6455-6461 (1999).
16. Kouskouti, A., Scheer, E., Staub, A., Tora, L. & Talianidis, I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol. Cell 14, 175-182 (2004).
17. Xiao, B. et al. Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 421, 652-656 (2003).
18. Grand, R. J. et al. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Virology 210, 323-334 (1995).
19. Tachibana, M., Sugimoto, K., Fukushima, T. & Shinkai, Y. SET domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactjvityand specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309-25317 (2001).
20. Otwinowski, Z. & Minor, W. in Data Collection and Processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) 552-562 (SERC Daresbury Laboratory, Warrington, 1993).
21. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
22. Jones, T. A., Zhou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).